Lima, Peru, Sep 18, 2006 / 22:00 pm
A federal court in Lima has recognized the anti-implantation effect of the morning-after pill in a ruling that, at least temporarily, upholds an order to suspend the free distribution of the drug, in public hospitals.
The ruling recognizes what the drug manufactures have already admitted, namely that one of the mechanisms of the morning-after pill is to prevent implantation of a newly fertilized fetus in the uterine wall. This makes the drug potentially abortifacient in the eyes of Peruvian law—a fact that has been repeatedly denied by the country’s Health Minister, Pilar Mazzetti, who authorized the distribution of the drug. Peru’s constitution protects unborn humans from the moment of conception.
The September 6th ruling upholds a lower court’s decision to halt the distribution of the drug until its abortifacient mechanism could be ruled out. The Health Ministry appealed that ruling.
The federal court in Lima issued a 2-1 decision upholding the lower court’s decision and recognizing the anti-implantation mechanism of the drug.
A final hearing on the issue has been set for October 27.
Subscribe to our daily newsletter
At Catholic News Agency, our team is committed to reporting the truth with courage, integrity, and fidelity to our faith. We provide news about the Church and the world, as seen through the teachings of the Catholic Church. When you subscribe to the CNA UPDATE, we'll send you a daily email with links to the news you need and, occasionally, breaking news.
As part of this free service you may receive occasional offers from us at EWTN News and EWTN. We won't rent or sell your information, and you can unsubscribe at any time.
Click hereOur mission is the truth. Join us!
Your monthly donation will help our team continue reporting the truth, with fairness, integrity, and fidelity to Jesus Christ and his Church.
Donate to CNA